University of Missouri-Columbia School of Law,
Board of Editors, Missouri Law Review
Phi Kappa Phi; Omicron Delta Epsilon
Missouri USDC, Eastern District
US Ct Appeals, 11th Circuit (Covers AL, FL, GA)
International Cannabis Bar Association
Founding & Sustaining, Lifetime Member, 2015 - Present
National Cannabis Industry Association
Packaging and Labeling Committee, 2017 - 2019
Risk Management and Insurance Committee, 2019 - Present
Illinois State Bar Association
Bar Association of Metropolitan St. Louis
The Missouri Bar
Missouri Organization of Defense Lawyers
National Association of Railroad Trial Counsel
Chairman, Jury Instructions Committee, 1990-1998
The National Law Journal: “Winning: In Defending Tobacco Companies, Less Was More”
The American Lawyer: "Blazing Billables: State Laws Expand Pro-Pot Legal Work"
Listed in "The Best Lawyers in America®" 2014-2021 (by BL Rankings)
St Louis Business Journal: "How a High Profile Trial Lawyer Became Expert in Cannabis Law" 2019
Legal Champion Award, Missouri Lawyers Media 2012
Top Defense Verdict of the Year, Missouri Lawyers Media, 2011
Bloomberg News: “Tobacco Industry Doesn’t Owe Missouri Hospitals” (quoting Carl 's closing argument)
Listed in "Missouri & Kansas Super Lawyers", 2012-2016 (by Thomson Reuters)
Law360: “How They Won it: Taking Big Tobacco to the Jury”
The American Lawyer: "Am Law 200 Firms Grow National Pot Practices"
Thompson Coburn LLP
Moderator, "Highlights from Missouri Cannabis Business Breakfast," St. Louis, July 2019
Moderator, "Cannabis Business Issues - A Four Hour Seminar," St. Louis, December 2018
Moderator, "Cannabis Litigation in a Newly Regulated Environment," American Bar Association, San Diego, May 2018
Panelist, with former California Attorney General Bill Lockyer, "Cannabis Product Liability," The State of Cannabis, Long Beach, 2017
Panelist, "Product Liability & Mass Tort Litigation: Will the Cannabis Industry be Next?"
National Cannabis Industry Association, Oakland, 2016
Lecturer, “The New NARTC Jury Instructions Book”
National Association of Railroad Trial Counsel, The Greenbriar, 1995
Lecturer, “Cross-Examination of Plaintiff’s Vocational Rehabilitation Expert”
National Association of Railroad Trial Counsel, Pebble Beach, 1994
Lecturer, “Semi-Annual Review of the Law”
Missouri Organization of Defense Lawyers, December 1991
Lecturer, “Let the Associate Handle the Instructions”
National Association of Railroad Trial Counsel, Chicago, 1990
Webster University, 1989-1990
Carl is a trial lawyer who chairs the Firm's Mass Tort Practice, co-chairs its Consumer Products Practice, and is a member of its Cannabis Practice. He has more than 30 years of experience in representing consumer product, manufacturing, and agricultural clients in courtrooms throughout the United States.
Carl has defended high-stakes business and personal injury cases for decades, including as lead trial counsel in the defense of billion-dollar damages claims. He first-chaired the largest defense jury verdict in the history of tobacco cost recovery litigation, a three-month trial with testimony from 49 witnesses. His cases and verdicts have been covered by the National Law Journal, the American Lawyer, the New York Times, the St. Louis Post-Dispatch, and other national media outlets.
Carl has decades of experience in preparing and cross-examining expert witnesses on complex epidemiologic, biostatistical, damages model, causal inference, product design, and addiction issues. He has litigated a wide variety of lawsuits, including dozens of complex business and commercial cases, as well as wrongful death, individual smoking & health, and asbestos-synergy cases. Carl has defended class actions, cases alleging false or misleading product labelling, consumer protection cases, targeted marketing lawsuits, mass consolidations of thousands of plaintiffs, and state attorneys general cases alleging false advertising.
Carl's cannabis practice is limited to issues relating to federally-legal hemp, assisting Firm clients in avoiding inadvertent violations of federal law, and providing advice on due diligence and precautions that foreclose and prevent potentially unlawful effects within the United States that could arise from doing business in foreign countries where cannabis is federally legal. He also advises Firm clients outside the industry on the legal and business risks of doing business with companies within the industry. Carl is a Lifetime and Sustaining Member of the International Cannabis Bar Association and has served on two committees of the National Cannabis Industry Association.
In addition to his current role as in-house counsel to the Firm, Carl has served on the Firm's Compensation Committee, Management Nominating Committee, Associate Review Committee, and as co-chair of its Tobacco Practice. His books on jury instructions, now in their third edition, have been in continuous publication for over 30 years.
Served as lead trial counsel for a major domestic cigarette manufacturer in a lawsuit tried against dozens of hospitals and hospital systems seeking more than $4 billion in compensatory damages. During the three-month trial, 26 jurors (including 14 alternates) heard testimony from 49 witnesses. Following seven days of deliberations, the jury returned defense verdicts on all claims by all plaintiffs. The National Law Journal described the win as "the largest defense victory in a tobacco cost-recovery suit to date."
Served as national trial counsel for major domestic tobacco manufacturers in a variety of lawsuits including class actions and multi-plaintiff smoking & health lawsuits.
Served as national trial counsel in asbestos litigation for a major consumer products manufacturer in mesothelioma cases.
Served as national coordinating counsel in mass tort litigation for one of the country's largest pneumatic power tool and equipment manufacturers, overseeing the defense of thousands of cases arising out of industrial and occupational exposures.
Served as national counsel for a major rail carrier in its hearing loss and cumulative trauma litigation, coordinating the defense of thousands of cases throughout the country.
"Just 1 Recreational Pot Dispensary in Metro East? Here's How Many More You Can Expect in 2020";
Quoted in the St. Louis Business Journal, December 31, 2019
"Missouri Cultivates 'Don't Ask, Don't Tell' Tax Policy for Flood of CBD Sales";
Quoted in the St. Louis Post Dispatch, September 24, 2019
"What St. Louis Lawyers Say About Marijuana Work So far, What's Ahead";
Quoted in the St. Louis Business Journal, September 20, 2019
"ABA Urges Congress to Reform Federal Cannabis Policy";
Author, Tracking Cannabis, August 22, 2019
"An 'Eye-Popping' Number of Applications File for Medical Marijuana Licenses";
Quoted in the St. Louis Business Journal, August 20, 2019
"How Stiff is the Competition for Missouri Marijuana Business Licenses?";
Quoted in the St. Louis Business Journal, August 15, 2019
"Cannabis-derived CBD Shops are Turning Up All Over St. Louis, As Laws, Science Try to Catch Up";
Quoted in the St. Louis Post Dispatch, July 21, 2019
"With Relaxed Rules, More Missouri Marijuana Applications Likely";
Quoted in the St. Louis Business Journal, May 30, 2019
"Missouri Medical Cannabis Business Licensing: March 2019 status";
Author, Tracking Cannabis, March 4, 2019
"Cannabis Packaging and Labeling: Recommendations for Sensible and Consistent Regulations Across States and Nations";
Reviewer, National Cannabis Industry Association, February 2019
"How a High-Profile St. Louis Trial Lawyer Became Expert in Cannabis Law";
Profiled in the St. Louis Business Journal, December 17, 2018
"What Marijuana Business Investors Need to Know";
Quoted in the St. Louis Business Journal, December 6, 2018
"Missouri's 2018 Medical Cannabis Initiatives";
Author, Tracking Cannabis, November 2018
"Top 5 Warning Signs for Cannabis Investors";
Author, Tracking Cannabis, September 2018
"Is San Francisco’s sugar-sweetened beverage rule watering down First Amendment rights?";
Author, Asia IP 2016
"Cannabis Product Liability";
Quoted in Bloomberg BNA, November 2016
"Thompson Coburn Takes Stage at Cannabis Business Summit";
Tracking Cannabis, July 6, 2016
"Am Law 200 Firms Grow National Pot Practices";
Quoted in The American Lawyer, June 2016
"Blazing Billables: State Laws Expand Pro-Pot Legal Work";
Quoted in The American Lawyer, April 2016
"UPDATE: Cannabis, pain reduction, and opioid abstinence";
Author, Tracking Cannabis, March 24, 2016
"Limiting Tort Liability for Cannabis: Failure to Warn Part I – the LivWell Lawsuit";
Author, Tracking Cannabis, October 14, 2015
"Limiting Tort Liability for Cannabis: Dram Shop-type Laws";
Author, Tracking Cannabis, September 21, 2015,
"Winning: In Defending Tobacco Companies, Less was More";
Mentioned in The National Law Journal, June 13, 2011
"How They Won It: Taking Big Tobacco to the Jury";
Mentioned in Law360, May 11, 2011
"$1 billion on the Line as Missouri Hospitals Take on Tobacco";
Mentioned in the St. Louis Business Journal, November 26, 2010
"Illinois Non-Pattern Jury Instructions – Annotated IPI Companion - (Third Edition)";
Author, Book, West Group, New York, 2001
"Enemies List: A Vigilant Journalist’s Plea for a Renewed Red Scare";
Contributor, in P.J. O’Rourke, Atlantic Monthly Press, New York, 1996
“Medico-Legal Aspects of Head Injury”;
Author, Book Chapter, in Head Injury & Post-Concussive Syndrome, Churchill Livingstone, Inc., New York, 1995
"Illinois Non-Pattern Jury Instructions - (Second Edition)";
Author, Book, Lawyer’s Cooperative Publishing Company, New York, 1991
“Missouri’s Federal Employers Liability Act Verdict Director Denies Railroad Defendants a Fair Trial”;
Author, St. Louis Bar Journal, Fall, 1989
“Intrastate Forum Non Conveniens in Missouri”;
Author, 47 Journal of the Missouri Bar II, January-February, 1991
“Distinctive Aspects of Litigation Under the Federal Employers Liability Act: An Overview”;
Author, The St. Louis Bar Journal, Fall, 1989
"Illinois Non-Pattern Jury Instructions";
Author, Book, The Lawsource Publishing Company, Chicago, 1987
“Federal Employers Liability Act Cases -- Instructing on Sole Cause”;
Author, Journal of the Missouri Bar, April-May, 1988
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an â€˜engagement letterâ€™).
By clicking the â€˜ACCEPTâ€™ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the â€˜ACCEPTâ€™ button if you understand and accept the foregoing statement and wish to proceed.